Survival Benefit of Recombinant Human Erythropoietin Administration prior to Onset of End-Stage Renal Disease: Variations across Surrogates for Quality of Care and Time
Lu, Wei X., Jones-Burton, Charlotte, Zhan, Min, Salzberg, Daniel J., Moore, Jr., Jack, Fink, Jeffrey C.Volume:
101
Year:
2005
Language:
english
Journal:
Nephron Clinical Practice
DOI:
10.1159/000086226
File:
PDF, 143 KB
english, 2005